Results 241 to 250 of about 754,642 (308)

Development and analytical evaluation of a microneutralization cytopathic effect assay for human adenovirus type 55-specific neutralizing antibodies. [PDF]

J Microbiol
Jung DI, Park Y, Choi JA, Kwon SH, Lee JY, Song M, Seo SH.   +6 more
europepmc   +1 more source

Self‐Propelled HPB@Lip@AB Nanomotors Ameliorate Dry Eye Disease

Advanced Science, EarlyView.
A self‐propelled HPB@Lip@AB nanomotor system is developed for dry eye disease (DED) therapy, facilitating rapid penetration across ocular surface barriers while integrating hydrogen therapy with multi‐enzyme‐like antioxidant activity. The nanoplatform restores mitochondrial function, suppresses oxidative stress, inflammation, and apoptosis, and ...
Jing Li, Xi Wan, Xinru Su, Zechuan Li, Yue Wang, Ying Wang, Ruofei Li, Huangzhao Wei, Jianbin Zhang, Shuai Wang   +9 more
wiley   +1 more source

A DirectView focus reduction assay for high-throughput quantification of neutralizing antibodies against influenza A and B viruses. [PDF]

Cell Rep Methods
Feng C, Rowe T, Currier M, Dong R, Huang Y, Atteberry G, Wang L, Hatta M, Davis CT, Wentworth DE, Zhou B.   +10 more
europepmc   +1 more source

Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques. [PDF]

Immunity
Mishra N, Liang B, Roark RS, Ghosh AR, Callaghan S, Lee WH, Li X, Vo AL, Avillion G, Chowdhury RR, Habib R, Bibollet-Ruche F, Giese G, Oberoi P, Amereh K, Somanathan A, Zhu Y, Zhang Y, Kassab M, Tjio L, Andrabi S, Reyes RA, Allen JD, James NE, Randall KN, van der Maas L, Ben-Akiva E, Kacmarek-Michaels K, Plante S, Martella CL, Skelly AN, Singh A, Hurtado J, Dueker K, Capozzola T, Nedellec R, Ozorowski G, Lewis MG, Falcone S, Carfi A, Himansu S, Shapiro L, Crispin M, Hahn BH, Briney B, Irvine DJ, Burton DR, Ward AB, Batista FD, Kwong PD, Shaw GM, Andrabi R.   +51 more
europepmc   +1 more source

Mirusha virus: A novel sand fly-borne phlebovirus with evidence of neutralizing antibodies in humans and dogs in Kosovo. [PDF]

One Health
Jakupi X, Kurum E, Xhekaj B, Hoxha I, Walochnik J, Dvořák V, Hajdari D, Abazi P, Obwaller AG, Stefanovska J, Cvetkovikj A, Sherifi K, Charrel R, Kniha E, Platzgummer K, Ayhan N.   +15 more
europepmc   +1 more source

New Insights Into an Old Vaccine: Potency and Breadth of Neutralizing Antibodies Elicited by Yellow Fever Vaccine 17D Are Boosted by Heterologous Orthoflavivirus Infection. [PDF]

J Infect Dis
Coulter FJ, Micheletti CA, Estrada AE, Luo S, Osman SR, Nix CD, Hu SY, Sampouw SM, Kareko BW, Naleway AL, Messer WB.   +10 more
europepmc   +1 more source

Could AAV-vectored delivery of broadly neutralizing antibodies (bNAbs) reduce virologic failure in children diagnosed with perinatal HIV? [PDF]

Hum Vaccin Immunother
Pringle KL, Martins MA.
europepmc   +1 more source

Development of a Norway rat hepacivirus reporter for high-throughput quantification of neutralizing antibodies. [PDF]

J Virol
Kennedy MJ, Wolfisberg R, Lundsgaard EA, Thorselius CE, Collignon L, Nielsen L, Holmbeck K, Bukh J, Scheel TKH.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Production of Neutralizing Antibody

2018
Techniques employing monoclonal antibodies (mAbs) are widely used in the initial development phase of biologics. The usefulness of mAbs in basic RA research has been established based on their characteristics, including specificity of binding, homogeneity, and ability to be produced on a large scale.
Erika, Takemasa, Shuang, Liu, Hitoshi, Hasegawa   +2 more
openaire   +2 more sources